No Detail Found!

Efficacy of ticagrelor and clopidogrel in treating unstable angina and their effects on serum inflammatory factors

Author(s)
Donghui Qin Department of Pharmacy, Qiqihar Second Hospital,,China
Yuanyuan Ren Department of Cardiology, the Third Affiliated Hospital of Qiqihar Medical College,,China
Na Zhang Department of Cardiology, the Third Affiliated Hospital of Qiqihar Medical College,,China
Xue Yang Department of Cardiology, the Third Affiliated Hospital of Qiqihar Medical College,,China
Zhuo Chen Department of Cardiology, the Third Affiliated Hospital of Qiqihar Medical College,,China
Changliang Zhao Department of Cardiology, the Third Affiliated Hospital of Qiqihar Medical College,,China
Abstract
To evaluate the comparative efficacy of Ticagrelor and Clopidogrel in treating patients with coronary heart disease and unstable angina, as well as their effects on serum inflammatory factors, thereby providing a solid foundation for future clinical diagnosis and treatment. The frequency of angina attacks in the Ticagrelor group was lower than in the Clopidogrel group (P< 0.05). The duration of angina and shortness of breath were also shorter in the Ticagrelor group (P<0.05). The levels of C-reactive protein (CRP), interleukin-6 (IL-6), interleukin-18 (IL-18), matrix metalloproteinase-9 (MMP-9), lipoprotein-associated phospholipase A2 (Lp-PLA2), myeloperoxidase (MPO), type 1 tissue plasminogen activator inhibitor (tPAI-1), homocysteine (Hcy), endothelin-1 (ET-1), tumor necrosis factor-alpha (TNF-a), plateletderived growth factor (PDGF), brain natriuretic peptide (BNP), soluble CD40 ligand (sCD40L), soluble vascular cell adhesion molecule-1 (sVCAM-1), soluble intercellular adhesion molecule (sLCAM-1), low-density lipoprotein cholesterol (LDL-C), total cholesterol (TC), and triglycerides (TG), as well as the incidence of MACCE events, were all lower in the Ticagrelor group compared to the Clopidogrel group (P<0.05), while high-density lipoprotein cholesterol (HDL-C) levels and overall efficacy were higher in the Ticagrelor group (P<0.05). Ticagrelor demonstrates superior therapeutic efficacy compared to Clopidogrel in patients with coronary heart disease and unstable angina, effectively reducing serum inflammatory factor levels.
Publication Details
Page(s) 77-82
Published Journal: Pakistan Journal of Pharmaceutical Sciences, Volume: 38, Issue: 1, Year: 2025

Request the full text from PASTIC

Keywords
Unstable angina, clopidogrel, adverse reactions, Ticagrelor, bleeding events, serum inflammatory factor levels, major adverse cardiovascular and cerebrovascular events (MACCE), blood lipid levels, angina attacks
References
Byrne RA,Luscher TF,Neumann FJ .2023 .2023 ESC guidelines for the management of acute coronary syndromes. Eur. Heart J., 44(38) : 3720-3826.
Dragan PD,Popescu M,Marginean CO M .2023 .The role of systemic oxidative status in coronary arterial and peripheral venous blood of patients with unstable angina pectoris. Life (Basel), 13(7) : 1537.
Gimbel M,Sattar N,Packer M .2020 .Clopidogrel versus ticagrelor or prasugrel in patients aged 70 years or older with non-ST-elevation acute coronary syndrome (POPular AGE): The randomised, open-label, non-inferiority trial. Lancet, 395(10233) : 1374-1381.
Kabil MF,El-Sherbiny IM .2022 .Abo Dena AS. , 47 : 91-111.
Kuszynski DS,Lauver DA,Robinson BM .2022 .Pleiotropic effects of clopidogrel. , 18(3) : 253-265.
Lee H,Kim Y,Park J .2021 .The impact of ticagrelor on lipid profiles and cardiovascular risk: A systematic review and meta-analysis. Cardiovasc. Drugs Ther, 35(2) : 249-258.
Li P,Wu Y,Zhang Y .2021 .Efficacy and safety of Tongxinluo capsule as adjunctive treatment for unstable angina pectoris: A systematic review and meta-analysis of randomized controlled trials. Front, 12 : 742978.
Liu Y,Chen X,Zhang H X .2023 .The relation between atherogenic index of plasma and cardiovascular outcomes in prediabetic individuals with unstable angina pectoris. BMC Endocr, 23(1) : 187.
Liu L,Luo F,Zhang Y F .2022 .Alterations in the fecal microbiota and serum metabolome in unstable angina pectoris patients. Front. Biosci, 27(3) : 100.
Roos A,Edgren G,Holzmann MJ G .2022 .Unstable angina pectoris with myocardial injury versus myocardial infarction in the era of high-sensitivity cardiac troponin. Am. J. Cardiol., 169 : 32-41.
Sanderson NC,Parker WAE,Storey RF .2021 .Ticagrelor: Clinical development and future potential. Rev. Cardiovasc. Med, 22(2) : 373-394.
Su Q,Li H,Wang X .2022 .The mechanism of inflammatory factors and soluble vascular cell adhesion molecule-1 regulated by nuclear transcription factor NF-κB in unstable angina pectoris. J. Immunol. Res., 6137219 : .
Van Nunen LX,Johnson NP,McEwan P .2023 .Ticagrelor in stable coronary disease. Heart, 110(2) : 77-78.
Watanabe H,Shimizu K,Otsuka T .2024 .Clopidogrel vs aspirin monotherapy beyond 1 year after percutaneous coronary intervention. J. Am. Coll. Cardiol., 83(1) : 17-31.
Wang D,Yang XH,Zhang JD,Li RB,Jia M,Cui XR. .2018 .Compared efficacy of clopidogrel and ticagrelor in treating acute coronary syndrome: A metaanalysis. BMC Cardiovasc, 18(1) : 217.
0

Citations

0

Downloads

73

Views